Back to top

Entera Bio announces data for EB613 to be presented at ASBMR 2025

Entera Bio (ENTX) announced that new data exploring the dual actions of EB613 on trabecular and cortical bone was selected for oral presentation at...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Entera Bio Ltd. (ENTX)